The global ultrasound market, valued at $8.65 billion in 2023, is forecast to grow at a compound annual growth rate (CAGR) of 6.8%, reaching $13.87 billion by 2030, according to a report from research firm MarketsandMarkets.

Factors driving this growth include rising rates of chronic diseases, advancements in ultrasound technology, and increasing demand for noninvasive diagnostic tools.

Leading players in the global ultrasound market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, and FUJIFILM Holdings.
Key market drivers
The growing prevalence of chronic conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders has heightened the need for advanced diagnostic technologies, including ultrasound. The adoption of noninvasive, real-time imaging techniques has also gained traction, supported by an emphasis on early detection and monitoring of medical conditions.

Technological advancements, including AI, 3D and 4D imaging, and portable devices, have expanded the versatility and accessibility of ultrasound systems. These innovations are particularly valuable for applications ranging from cardiology to obstetrics and vascular diagnostics.

Segment insights
The color ultrasound segment is expected to experience the highest growth rate during the forecast period. With its ability to produce high-resolution, real-time images, color ultrasound is particularly effective for cardiovascular and vascular diagnostics, as well as obstetric imaging. The integration of Doppler technology enhances the capability to visualize blood flow and tissue movement, addressing increasing demand for precision in clinical diagnostics.

In terms of application, vascular imaging is projected to lead the market due to the rising incidence of vascular diseases, such as atherosclerosis and deep vein thrombosis. The noninvasive nature and cost-effectiveness of ultrasound make it a preferred choice for evaluating blood flow, detecting blockages, and diagnosing vessel-related conditions.

Europe currently holds the largest share of the ultrasound market, driven by strict regulatory standards, strong investment in healthcare research, and the widespread availability of trained professionals. The adoption of portable and point-of-care ultrasound devices is also accelerating growth in the region.

As the demand for early detection and advanced imaging continues to grow, the ultrasound market is poised for significant expansion. Technological innovation and the increasing prevalence of chronic conditions are expected to remain key factors shaping the industry's trajectory.

Back to HCB News

Ultrasound Homepage